Aker BioMarine ASA (OSL:AKBM)

Aker BioMarine ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,201	5,884	4,033	3,335	4,756	10,291
Market Cap Growth	-11.53%	45.89%	20.94%	-29.89%	-53.79%	-
Enterprise Value	6,850	7,308	8,170	7,246	7,421	12,373
Last Close Price	59.30	67.10	25.59	21.16	30.20	65.36
PE Ratio	2.61	2.87	-	33.85	-	-
Forward PE	62.67	179.33	80.58	30.13	-	26.43
PS Ratio	2.46	2.60	2.03	1.22	2.06	4.16
PB Ratio	2.90	2.98	1.09	0.89	1.46	3.22
P/TBV Ratio	10.52	6.91	1.79	1.54	2.68	6.23
P/FCF Ratio	-	-	265.14	-	-	-
P/OCF Ratio	176.56	42.45	8.39	22.42	207.63	-
EV/Sales Ratio	3.23	3.23	4.10	2.65	3.21	5.00
EV/EBITDA Ratio	22.93	17.58	179.04	12.04	21.88	29.02
EV/EBIT Ratio	-	-	-	45.12	-	165.60
EV/FCF Ratio	-54.72	-	537.11	-	-	-
Debt / Equity Ratio	1.01	0.85	1.07	1.01	0.88	0.65
Debt / EBITDA Ratio	6.08	3.81	42.72	5.82	7.37	4.33
Debt / FCF Ratio	-	-	262.00	-	-	-
Asset Turnover	0.34	0.33	0.24	0.35	0.36	0.41
Inventory Turnover	0.93	0.93	0.65	0.97	1.38	1.68
Quick Ratio	1.19	1.21	0.83	0.84	0.93	1.05
Current Ratio	3.47	3.79	2.57	2.85	3.10	3.15
Return on Equity (ROE)	-5.22%	-5.29%	-8.67%	2.67%	-2.15%	-2.07%
Return on Assets (ROA)	-0.27%	-0.55%	-0.78%	1.29%	-0.59%	0.78%
Return on Capital (ROIC)	-0.29%	-0.61%	-0.85%	1.40%	-0.66%	0.92%
Return on Capital Employed (ROCE)	-	-	-	2.30%	-	1.40%
Earnings Yield	38.25%	34.81%	-2.26%	2.95%	-1.48%	-0.46%
FCF Yield	-2.41%	-1.00%	0.38%	-7.50%	-14.10%	-6.05%
Buyback Yield / Dilution	-2.46%	-0.02%	-0.04%	-0.05%	-12.20%	-13.05%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.